GLP-1 Pill Rybelsus approved for Type 2
The first GLP-1 agonist pill for Type 2 diabetes has been approved by the European Medicines Agency (EMA). Rybelsus (known as oral semaglutide in clinical trials) is a once-daily
The first GLP-1 agonist pill for Type 2 diabetes has been approved by the European Medicines Agency (EMA). Rybelsus (known as oral semaglutide in clinical trials) is a once-daily
University of Leicester research shows that as many as one in three people with Type 2 diabetes are not taking recommended diabetes medication. The research
As reported in Diabetes Health, DV-100, a drug designed to halt the body’s autoimmune attack on pancreatic beta cells that leads to type 1 disease,
In December AstraZeneca announced an agreement under which it will acquire the entirety of Bristol-Myers Squibb’s interests in the companies’ diabetes alliance for an initial
A Chinese research study of diabetes patients with coronary heart disease concluded that metformin is more effective than glipizide in reducing the risk of major
People with Type 2 diabetes in Scotland have access to a new drug after physicians were given the go ahead by the Scottish Medicines Consortium